A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults (NCT06620003)

🧪 Interventions in This Study

• cAd3-Marburg Vaccine (BIOLOGICAL)
• Placebo (BIOLOGICAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (7 Sites)

• Optimal Research; LLC — Huntsville, Alabama
• Synexus Clinical Research US, Inc. — Phoenix, Arizona
• Optimal Research; LLC — Melbourne, Florida
• Synexus Clinical Research US, Inc. — Chicago, Illinois
• Optimal Research; LLC — Peoria, Illinois
• Synexus Clinical Research US; Inc. — Dallas, Texas
• Synexus Clinical Research US, Inc. — San Antonio, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Marburg Virus Disease

• A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health — Washington D.C., District of Columbia

Explore by condition: All Marburg Virus Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.